-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma (Part 4 of a 4-Part Series) - 12/8/2023
1:55:17
-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia (Part 3 of a 4-Part Series)
1:59:50
-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma (Part 2 of a 4-Part Series) - 12/8/2023
2:03:20
-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma (Part 1 of a 4-Part Series) - 12/8/2023
2:27:27
-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer - 12/7/2023
2:01:52
-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer - 12/6/2023
1:30:06
-
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer - 12/5/2023
2:00:37
-
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers - 11/29/2023
1:00:25
-
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer - 11/14/2023
1:30:16
-
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer - 11/9/2023
1:03:09
-
Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers - 11/7/2023
1:01:24
- Next Page
